J. Bonafous

Phase II scintigraphic clinical trial of malignant melanoma and metastases with iodine-123-N-(2-diethylaminoethyl 4-iodobenzamide).

J. Michelot, Marie‐France Moreau, A. Veyre et al. · PubMed · 1993 · 119 citations

Primary Melanomas, Surgical Oncology, Engineering +15

Synthesis and evaluation of new iodine-125 radiopharmaceuticals as potential tracers for malignant melanoma.

J. Michelot, Marie‐France Moreau, P.G. Labarre et al. · PubMed · 1991 · 89 citations

Engineering, Malignant Melanoma, New Iodine-125 Radiopharmaceuticals +18

123 I- N -(2-diethylaminoethyl)-2-iodobenzamide: a potential imaging agent for cutaneous melanoma staging

Nicole Moins, M. D’Incan, J. Bonafous et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2002 · 72 citations

Potential Imaging Agent, I- N, Engineering +13

Early detection and monitoring of cartilage alteration in the experimental meniscectomised guinea pig model of osteoarthritis by 99mTc-NTP 15-5 scintigraphy

Elisabeth Miot-Noirault, Aurélien Vidal, Philippe Pastoureau et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2007 · 24 citations

Musculoskeletal Research, Cartilage Alteration, Musculoskeletal Imaging +11

Joint scintigraphy in rabbits with 99mtc-N-[3-(triethylammonio)propyl]-15ane-N5, a new radiodiagnostic agent for articular cartilage imaging.

Monique Ollier, Jean‐Claude Maurizis, C. Nicolas et al. · PubMed · 2001 · 21 citations